martes, 9 de diciembre de 2025
Structure reports promising weight loss outcomes with obesity drug, but side effect questions loom Structure’s drug is a small molecule pill, which comes with manufacturing advantages and convenience for patients
https://www.statnews.com/2025/12/08/structure-obesity-oral-small-molecule-aleniglipron-side-effects/
By Elaine ChenDec. 8, 2025
National Biotech Reporter
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario